Skip to main content
. 2018 Mar 15;10(3):356. doi: 10.3390/nu10030356

Table 2.

Effect of standardized extract (KBH-JP-040) on aggrecan, collagen type-II, inflammatory cytokines, matrix metaloproteins, PGE2 and ROS generation in rat chondrocytes.

NC RhIL-1 RhIL-1+KBH-JP-040 50 RhIL-1+KBH-JP-040100 RhIL-1+KBH-JP-040200
Aggrecan (ng/mL) 12.88 ± 0.62 10.90 ± 0.60 ** 11.54 ± 1.30 * 11.57 ± 1.05 **,## 11.74 ± 1.06 **,#
Collagen type II (ng/mL) 12.85 ± 1.15 9.51 ± 0.48 ** 11.80 ± 0.54 **,# 12.93 ± 3.81 *,## 13.32 ± 1.22 *,##
IL-6 (pg/mL) 35.20 ± 8.24 60.30 ± 0.76 51.66 ± 2.44 51.24 ± 1.60 50.63 ± 5.32
IL-10 (pg/mL) 3.34 ± 2.06 3.53 ± 1.66 *** 4.00 ± 1.43 ** 4.79 ± 2.95 *,# 4.65 ± 3.35 *
IL-12 (pg/mL) 1.32 ± 0.67 2.30 ± 0.64 ** 1.51 ± 0.36 *,## 1.39 ± 0.24 ### 1.01 ± 0.52 ###
MMP1 (pg/mL) 52.98 ± 10.69 93.06 ± 34.37 *** 46.19 ± 30.69 ***,# 38.31 ± 15.35 **,### 41.37 ± 12.95 **,###
MMP9 (pg/mL) 34.82 ± 12.80 54.05 ± 10.05 *** 39.24 ± 4.94 ***,# 38.43 ± 5.88 **,### 33.21 ± 3.45 **,###
MMP13 (pg/mL) 189.35 ± 23.33 269.50 ± 37.08 ** 211.45 ± 20.37 * 208.25 ± 38.84 # 192.15 ± 38.73
PGE2 (pg/mL) 58.30 ± 1.33 81.78 ± 1.19 ** 54.32 ± 0.81 * 41.20 ± 0.69 # 47.22 ± 2.50
ROS (%) 545.20 ± 17.25 645.40 ± 36.73 *** 563.20 ± 6.45 **,# 567.60 ± 11.01 *,## 555.60 ± 13.43 **,#

NC, normal chondrocytes; RhIL-1, 5 ng/mL recombinant human IL-1-treated group; RhIL-1+ KBH-JP-04050, rhIL-1 and standardized extract , KBH-JP-040 50 μg/mL-treated group; RhIL-1+ KBH-JP-04050, rhIL-1 and KBH-JP-040 50 μg/mL-treated group; RhIL-1+ KBH-JP-040100, rhIL-1 and KBH-JP-040 100 μg/mL-treated group; RhIL-1+ KBH-JP-04050, rhIL-1 and KBH-JP-040 150 μg/mL-treated group. IL interleukin; MMP matrix metalloproteinases, PGE2 prostaglandins E2; ROS reactive oxygen species. All experiments were performed using three replicates. The data are reported as means ± SD. *: p < 0.05; **: p < 0.01; and ***: p < 0.001, Bonferroni post hoc test following one-way ANOVA versus the mock group; #: p < 0.05; ##: p < 0.01; and ###: p < 0.001, Bonferroni post hoc test following one-way ANOVA versus RhIL-1 group.